Amlodipine/olmesartan
(Redirected from
Olmesartan/amlodipine
)
Combination of | |
---|---|
Angiotensin II antagonist | |
Clinical data | |
Trade names | Azor, Sevikar |
Other names | Olmesartan/amlodipine |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
License data | |
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
KEGG |
Amlodipine/olmesartan, sold under the brand name Azor, among others is a
olmesartan medoxomil, an angiotensin II receptor blocker.[5]
Amlodipine/olmesartan was approved for medical use in the United States in September 2007.generic medication.
Medical uses
The combination is
indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure.[5]
History
The combination has been studied in clinical trials; one test showed it reduced blood pressure during a 24-hour period and was well tolerated.[8]
References
- ^ "TGA eBS - Product and Consumer Medicine Information Licence". www.ebs.tga.gov.au.
- ^ "OLAMLO, OLMAKAR, OLMESARTAN/AMLODIPINE ASTRON, OLMESARTAN/AMLODIPINE INTAS (Accord Healthcare Pty Ltd)". Department of Health and Aged Age. Retrieved 3 April 2023.
- ^ "SEVIKAR 20/5 olmesartan medoxomil / amlodipine (as besilate) 20/5 mg tablet blister pack (157565)". Therapeutic Goods Administration (TGA). 27 May 2022. Retrieved 3 April 2023.
- ^ "Sevikar 20 mg/5 mg Film-Coated Tablets - Summary of Product Characteristics (SmPC)". (emc). 11 July 2022. Retrieved 19 March 2023.
- ^ a b c d e "Azor- amlodipine besylate and olmesartan medoxomil tablet, film coated". DailyMed. 7 September 2022. Retrieved 17 March 2023.
- ^ "Azor- amlodipine besylate and olmesartan medoxomil tablet, film coated". DailyMed. 7 June 2022. Retrieved 18 March 2023.
- ^ "Drug Approval Package: Azor (amlodipine and olmesartan medoxomil) NDA #022100". U.S. Food and Drug Administration (FDA). 17 December 2009. Retrieved 17 March 2023.
- PMID 19572050.